Skip to main content

Annals of Surgical Oncology

Ausgabe 12/2016

Inhalt (47 Artikel)

Gastrointestinal Oncology

What’s New in Gastric and Esophageal Cancers

Kenneth Tanabe

Gastrointestinal Oncology

Advances in Imaging and Endoluminal Therapies for Early Esophageal and Gastric Cancers

Neil Sengupta, Mandeep S. Sawhney

Gastrointestinal Oncology

What’s the Best Way to Treat GE Junction Tumors? Approach Like Gastric Cancer

John T. Mullen, Eunice L. Kwak, Theodore S. Hong

Gastrointestinal Oncology

Exploiting Molecular and Immune Biology of Gastric and Gastroesophageal Adenocarcinomas to Discover Novel Therapeutic Targets

Elena Elimova, Shumei Song, Yusuke Shimodaira, Quan Lin, Jaffer A. Ajani

Gastrointestinal Oncology

Minimally Invasive Gastric Surgery

Gabriel Herrera-Almario, Vivian E. Strong

Thoracic Oncology

Gastroesophageal Junction Tumors

Nabil Rizk

Open Access Breast Oncology

Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Ductal Carcinoma In Situ

Monica Morrow, Kimberly J. Van Zee, Lawrence J. Solin, Nehmat Houssami, Mariana Chavez-MacGregor, Jay R. Harris, Janet Horton, Shelley Hwang, Peggy L. Johnson, M. Luke Marinovich, Stuart J. Schnitt, Irene Wapnir, Meena S. Moran

Breast Oncology

The Association of Surgical Margins and Local Recurrence in Women with Ductal Carcinoma In Situ Treated with Breast-Conserving Therapy: A Meta-Analysis

M. Luke Marinovich, Lamiae Azizi, Petra Macaskill, Les Irwig, Monica Morrow, Lawrence J. Solin, Nehmat Houssami

Breast Oncology

Type and Extent of Surgery for Screen-Detected and Interval Cancers at Blinded Versus Nonblinded Double-Reading in a Population-Based Screening Mammography Program

Roy J. P. Weber, Rob M. G. van Bommel, Wikke Setz-Pels, Adri C. Voogd, Elisabeth G. Klompenhouwer, Marieke W. Louwman, Luc J. A. Strobbe, Vivianne C. G. Tjan-Heijnen, Lucien E. M. Duijm

Breast Oncology

Different Prognostic Implications of Residual Disease After Neoadjuvant Treatment: Impact of Ki 67 and Site of Response

Sebastian Diaz-Botero, Martin Espinosa-Bravo, Victor Rodrigues Gonçalves, Antonio Esgueva-Colmenarejo, Vicente Peg, Jose Perez, Javier Cortes, Isabel T. Rubio

Breast Oncology

Mucocele-Like Lesions of the Breast: Rate of Upstaging and Cancer Development

Waleed O. Gibreel, Judy C. Boughey

Breast Oncology

Comparative Analysis of Breast Cancer Phenotypes in African American, White American, and West Versus East African patients: Correlation Between African Ancestry and Triple-Negative Breast Cancer

Evelyn Jiagge, Aisha Souleiman Jibril, Dhananjay Chitale, Jessica M. Bensenhaver, Baffour Awuah, Mark Hoenerhoff, Ernest Adjei, Mahteme Bekele, Engida Abebe, S. David Nathanson, Kofi Gyan, Barbara Salem, Joseph Oppong, Francis Aitpillah, Ishmael Kyei, Ernest Osei Bonsu, Erica Proctor, Sofia D. Merajver, Max Wicha, Azadeh Stark, Lisa A. Newman

Breast Oncology

Oncofertility Knowledge, Attitudes, and Practices of Canadian Breast Surgeons

Ellen Warner, Samantha Yee, Erin Kennedy, Karen Glass, Shu Foong, Maureen Seminsky, May Lynn Quan

Breast Oncology

Locoregional Recurrence Risk for Postmastectomy Breast Cancer Patients With T1–2 and One to Three Positive Lymph Nodes Receiving Modern Systemic Treatment Without Radiotherapy

Shih-Fan Lai, Yu-Hsuan Chen, Wen-Hung Kuo, Huang-Chun Lien, Ming-Yang Wang, Yen-Shen Lu, Chiao Lo, Sung-Hsin Kuo, Ann-Lii Cheng, Chiun-Sheng Huang

Breast Oncology

Body Mass Index and Locoregional Recurrence in Women with Early-Stage Breast Cancer

Laura E. G. Warren, Jennifer A. Ligibel, Yu-Hui Chen, Linh Truong, Paul J. Catalano, Jennifer R. Bellon

Breast Oncology

Adjuvant Radiotherapy in Early-Stage Breast Cancer: Evidence-Based Options

Chirag Shah, Rahul Tendulkar, Timothy Smile, Anish Nanavati, Bindu Manyam, Ehsan Balagamwala, Yvonne Pham, Radhika Takiar, Jessica Wobb, Atif Khan, Douglas Arthur, David Wazer, Frank Vicini

Colorectal Cancer

Sarcopenia is Associated with Chemotherapy Toxicity in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer

Stéphanie Chemama, Mohamed Amine Bayar, Emilie Lanoy, Samy Ammari, Annabelle Stoclin, Diane Goéré, Dominique Elias, Bruno Raynard, Sami Antoun

Colorectal Cancer

Effect of Neoadjuvant Radiation Dose and Schedule on Nodal Count and Its Prognostic Impact in Stage II–III Rectal Cancer

Wim Ceelen, Wouter Willaert, Machteld Varewyck, Sasha Libbrecht, Els Goetghebeur, Piet Pattyn

Colorectal Cancer

Risk Stratification in Patients with Stage II Colon Cancer

Ramzi Amri, Jonathan England, Liliana G. Bordeianou, David L. Berger

Colorectal Cancer

Short Chemotherapy-Free Interval Improves Oncological Outcome in Patients Undergoing Two-Stage Hepatectomy for Colorectal Liver Metastases

P. Kambakamba, M. Linecker, F. A. Alvarez, P. Samaras, C. S. Reiner, D. A. Raptis, P. Kron, E. de Santibanes, H. Petrowsky, P. A. Clavien, M. Lesurtel

Colorectal Cancer

Immature Colon Carcinoma Transcript-1 (ICT1) Expression Correlates with Unfavorable Prognosis and Survival in Patients with Colorectal Cancer

Xinyuan Lao, Qingyang Feng, Guodong He, Meiling Ji, Dexiang Zhu, Pingping Xu, Wentao Tang, Jianmin Xu, Xinyu Qin

Colorectal Cancer

Variation in the Use of Chemoradiotherapy for Stage II and III Anal Cancer: Analysis of the National Cancer Data Base

Cristina B. Geltzeiler, Vassiliki L. Tsikitis, Jong S. Kim, Charles R. Thomas Jr., Daniel O. Herzig, Kim C. Lu

Gastrointestinal Oncology

Aberrant Methylation of FOXE1 Contributes to a Poor Prognosis for Patients with Colorectal Cancer

Keishi Sugimachi, Tae Matsumura, Teppei Shimamura, Hidenari Hirata, Ryutaro Uchi, Masami Ueda, Shotaro Sakimura, Tomohiro Iguchi, Hidetoshi Eguchi, Takaaki Masuda, Kazutoyo Morita, Kenji Takenaka, Yoshihiko Maehara, Masaki Mori, Koshi Mimori

Gastrointestinal Oncology

Significant Role of Palliative Gastrectomy in Selective Gastric Cancer Patients with Peritoneal Dissemination: A Propensity Score Matching Analysis

Run-Cong Nie, Shi Chen, Shu-Qiang Yuan, Xiao-Jiang Chen, Yong-Ming Chen, Bao-Yan Zhu, Hai-bo Qiu, Jun-Sheng Peng, Ying-Bo Chen

Open Access Gastrointestinal Oncology

Using the Comprehensive Complication Index to Assess the Impact of Neoadjuvant Chemoradiotherapy on Complication Severity After Esophagectomy for Cancer

Nina Nederlof, Annelijn E. Slaman, Pieter van Hagen, Ate van der Gaast, Ksenija Slankamenac, Suzanne S. Gisbertz, Jan J. B. van Lanschot, Bas P. L. Wijnhoven, Mark I. van Berge Henegouwen, J. J. Bonenkamp, O. R. C. Busch, M. A. Cuesta, G. A. P. Nieuwenhuijzen, J. T. M. Plukker, E. J. Spillenaar Bilgen, H. W. Tilanus

Gastrointestinal Oncology

CRS-HIPEC Prolongs Survival but is Not Curative for Patients with Peritoneal Carcinomatosis of Gastric Cancer

T. Boerner, A. Graichen, T. Jeiter, F. Zemann, P. Renner, L. März, Y. Soeder, H. J. Schlitt, P. Piso, M. H. Dahlke

Gastrointestinal Oncology

Digital Glissonectomy: A Safe Perihepatic Peritonectomy

Guillaume Passot, Bradford J. Kim, Delphine Vaudoyer, Vahan Kepenekian, Isabelle Bonnefoy, Naoual Bakrin, Eddy Cotte, Olivier Glehen

Gastrointestinal Oncology

The Multidisciplinary Approach to GI Cancer Results in Change of Diagnosis and Management of Patients. Multidisciplinary Care Impacts Diagnosis and Management of Patients

Cheryl Meguid, Richard D. Schulick, Tracey E. Schefter, Christopher H. Lieu, Megan Boniface, Nicole Williams, Jon D. Vogel, Csaba Gajdos, Martin McCarter, Barish H. Edil

Hepatobiliary Tumors

Feasibility of Routine Application of Gadoxetic Acid-Enhanced MRI in Combination with Diffusion-Weighted MRI for the Preoperative Evaluation of Colorectal Liver Metastases

Masahiro Tanaka, Yoji Kishi, Minoru Esaki, Satoshi Nara, Mototaka Miyake, Nobuyoshi Hiraoka, Masato Nagino, Kazuaki Shimada

Open Access Hepatobiliary Tumors

Posttreatment Surveillance in Patients with Prolonged Disease-Free Survival After Resection of Colorectal Liver Metastasis

Boris Galjart, Eric P. van der Stok, Joost Rothbarth, Dirk J. Grünhagen, Cornelis Verhoef

Endocrine Tumors

Transarterial Chemoembolization for Metastatic Neuroendocrine Tumors With Massive Hepatic Tumor Burden: Is the Benefit Worth the Risk?

Mio Kitano, Gail W. Davidson, Lawrence A. Shirley, Carl R. Schmidt, Gregory E. Guy, Hooman Khabiri, Joshua D. Dowell, Manisha H. Shah, Mark Bloomston

Open Access Endocrine Tumors

Prophylactic “First-Step” Central Neck Dissection (Level 6) Does Not Increase Morbidity After (Total) Thyroidectomy

Andreas Selberherr, Philipp Riss, Christian Scheuba, Bruno Niederle

Endocrine Tumors

Comparison of Learning Curves for Retroauricular and Transaxillary Endoscopic Hemithyroidectomy

Doh Young Lee, Dong Ju Oh, Ka Ram Kang, Min-Su Kim, Kyoung Ho Oh, Seung-Kuk Baek, Soon-Young Kwon, Jeong-Soo Woo, Kwang-Yoon Jung

Gynecologic Oncology

Complications of Robotic Gynecologic Surgery in the Severely Morbidly Obese

Jonathan A. Cosin, Michelle A. Brett Sutherland, Candace T. Westgate, Hongbin Fang

Open Access Head and Neck Oncology

Intraoperative Sentinel Lymph Node Evaluation: Implications of Cytokeratin 19 Expression for the Adoption of OSNA in Oral Squamous Cell Carcinoma

Richard Shaw, Anders Christensen, Kapil Java, Rehab El Maddani, Triantafillos Liloglou, Triantafyllou Asterios, Christian von Buchwald, Irene Wessel, Katalin Kiss, Andreas Kjaer, Giedrius Lelkaitis, Anna Long, Janet Risk, Max Robinson

Melanomas

Invasive Scalp Melanoma: Role for Enhanced Detection Through Professional Training

Brendan P. Lovasik, Ishna Sharma, Maria C. Russell, Grant W. Carlson, Keith A. Delman, Monica Rizzo

Melanomas

Pediatric and Adolescent Melanoma: A National Cancer Data Base Update

Patrick D. Lorimer, Richard L. White, Kendall Walsh, Yimei Han, Russell C. Kirks, James Symanowski, Meghan R. Forster, Terry Sarantou, Jonathan C. Salo, Joshua S. Hill

Pediatric Oncology

Improvements in the Treatment of Patients Suffering from Bladder-Prostate Rhabdomyosarcoma: A Report from the CWS-2002P Trial

Guido Seitz, Jörg Fuchs, Monika Sparber-Sauer, Ivo Leuschner, Jan Godzinski, Thomas Klingebiel, Andreas Schuck, Peter Martus, Tobias M. Dantonello, Ewa Koscielniak

Reconstructive Oncology

Fasciocutaneous Lotus Petal Flap for Perineal Wound Reconstruction after Extralevator Abdominoperineal Excision: Application for Reconstruction of the Pelvic Floor and Creation of a Neovagina

Joke Hellinga, Patrick C. K. H. Khoe, Boudewijn van Etten, Patrick H. J. Hemmer, Klaas Havenga, Martin W. Stenekes, Yassir Eltahir

Reconstructive Oncology

Postmastectomy Reconstruction Outcomes After Intraoperative Evaluation with Indocyanine Green Angiography Versus Clinical Assessment

Gustave K. Diep, Jane Yuet Ching Hui, Schelomo Marmor, Bruce L. Cunningham, Umar Choudry, Pamela R. Portschy, Todd M. Tuttle

Thoracic Oncology

Clinical Significance of FDG-PET to Predict Pathologic Tumor Invasion and Lymph Node Metastasis of Superficial Esophageal Squamous Cell Carcinoma

Takaoki Furukawa, Yoichi Hamai, Jun Hihara, Manabu Emi, Ichiko Yamakita, Yuta Ibuki, Morihito Okada

Thoracic Oncology

PSF1 (Partner of SLD Five 1) is a Prognostic Biomarker in Patients with Non-small Cell Lung Cancer Treated with Surgery Following Preoperative Chemotherapy or Chemoradiotherapy

Ryu Kanzaki, Hisamichi Naito, Kazuyoshi Kise, Kazuhiro Takara, Daisuke Eino, Masato Minami, Yasushi Shintani, Soichiro Funaki, Tomohiro Kawamura, Toru Kimura, Meinoshin Okumura, Nobuyuki Takakura

Urologic Oncology

Phase 1b Trial to Evaluate Tissue Response to a Second Dose of Intravesical Recombinant Adenoviral Interferon α2b Formulated in Syn3 for Failures of Bacillus Calmette–Guerin (BCG) Therapy in Nonmuscle Invasive Bladder Cancer

Neema Navai, William F. Benedict, Guangcheng Zhang, Alice Abraham, Nancy Ainslie, Jay B. Shah, H. Barton Grossman, Ashish M. Kamat, Colin P. N. Dinney

Urologic Oncology

High Absolute Monocyte Count Predicts Poor Clinical Outcome in Patients with Castration-Resistant Prostate Cancer Treated with Docetaxel Chemotherapy

Keisuke Shigeta, Takeo Kosaka, Shigehisa Kitano, Yota Yasumizu, Yasumasa Miyazaki, Ryuichi Mizuno, Toshiaki Shinojima, Eiji Kikuchi, Akira Miyajima, Hitoshi Tanoguchi, Shintaro Hasegawa, Mototsugu Oya

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.